title: Interferon therapy in multiple myeloma.
abstract: Alpha-interferon is an active agent in multiple myeloma. It proved to be beneficial in some but not all studies both in combined therapy with alkylating agents or as a single agent to prolong the plateau phase in patients in partial remission. The best strategy of administration has yet to be established.
authors.affiliation: Service d'Immunopathologie et d'Hématologie, Hôpital Saint Louis, Paris, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Brouet
mesh_terms: D000477:Alkylating Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000628:therapy*
chemical_list: D000477:Alkylating Agents; D016898:Interferon-alpha